Table 3 Treatment results of each groups
From: Evaluation of clinical risk factors for developing pleural empyema secondary to liver abscess
Variables | PE (−) (N = 120) | PE (+) (N = 114) | Total (N = 234) | P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Group1 (N = 120) | Pt. with Simple PE (N = 78) | Pt. with complicated pleural effusion (N = 36) | Total (N = 114) | P-value | ||||||
Group1 (N = 120) | Group2 (N = 78) | Group3 (N = 26) | Group4 (N = 10) | Total (N = 36) | P-value | |||||
Results | ||||||||||
PAD duration | 16.5 ± 34.5 | 18.4 ± 13.3 | 21.1 ± 8.5 | 28.1 ± 5.2 | 23.0 ± 8.3 | 0.014 | 19.9 ± 12.1 | 0.001 | 18.1 ± 26.1 | < 0.001 |
Hospital stays, days | 21.2 ± 29.4 | 24.1 ± 13.2 | 24.0 ± 8.6 | 38.5 ± 12.7 | 28.1 ± 11.7 | < 0.000 | 25.4 ± 12.9 | 0.128 | 23.2 ± 22.9 | 0.163 |
Treatment periods, days | 45.9 ± 21.6 | 50.6 ± 23.6 | 54.3 ± 24.3 | 91.5 ± 47.8 | 64.6 ± 36.0 | 0.009 | 55.0 ± 28.7 | 0.022 | 50.4 ± 25.7 | 0.018 |
Discharge without complication | 112 (93.3) | 71 (91.0) | 22 (84.6) | 6 (60.0) | 28 (77.8) | 0.179 | 99 (86.8) | 0.073 | 211 (90.0) | 0.124 |
Recurrence | 4 (3.3) | 3 (3.8) | 3 (11.5) | 2 (20.0) | 5 (13.9) | 0.603 | 8 (7.0) | 0.107 | 12 (5.1) | 0.244 |
Readmission due to complication, ≤90 days | 3 (2.5) | 2 (2.6) | 2 (7.7) | 0 | 2 (5.6) | 1.000 | 4 (3.5) | 0.590 | 7 (3.0) | 0.716 |
Hopeless discharge | 0 | 3 (3.8) | 1 (3.8) | 0 | 1 (2.8) | 1.000 | 4 (3.5) | 1.000 | 4 (1.7) | 0.055 |
Death | 3 (2.5) | 2 (2.6) | 0 | 0 | 0 | – | 2 (1.8) | 1.000 | 5 (2.1) | 1.000 |